missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Sars E2 Antibody (4A6C9), Novus Biologicals™

Sars E2 Antibody (4A6C9), Novus Biologicals™

Mouse Monoclonal Antibody

£104.00

Specifications

Antigen Sars E2
Clone 4A6C9
Dilution Western Blot 1:500-1:2000, ELISA 1:10000, Immunohistochemistry-Paraffin
Applications Western Blot
Classification Monoclonal
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18505822
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP1-28850-0.025ml 		0.025 mL
£104.00
25µL
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Sars E2 Monoclonal specifically detects Sars E2 in SARS-CoV samples. It is validated for Western Blot, ELISA.
Specifications

Specifications

Sars E2
Western Blot 1:500-1:2000, ELISA 1:10000, Immunohistochemistry-Paraffin
Monoclonal
Supernatant
Virus
Purified recombinant fragment of SARS-E2 glycoprotein precursor expressed in E. Coli.
Primary
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
4A6C9
Western Blot
Unconjugated
Mouse
Subclonal supernatant with No Preservative
IgG1
Tissue culture supernatant
Specific for SARS-E2.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.